Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Colorectal Cancer Treatment Market size was valued at USD 20.08 billion in 2024 and is expected to reach USD 34.28 billion by 2037, registering around 4.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of colorectal cancer treatment is assessed at USD 20.8 billion.
The rising prevalence of colorectal cancer globally, along with the growth in efficient treatment options, are expected to fuel the progress of this market. The growth of the market can also be attributed to factors such as the increasing advancement in diagnostic methods on a global level. As per American Cancer Society, in U.S, 101,420 new cases of colon cancer and 44,180 new cases of rectal cancer, were registered in 2019.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of colorectal cancer treatment is assessed at USD 20.8 billion.
Colorectal Cancer Treatment Market size was valued at USD 20.08 billion in 2024 and is expected to reach USD 34.28 billion by 2037, registering around 4.2% CAGR during the forecast period i.e., between 2025-2037.
Asia Pacific industry is estimated to account for largest revenue share by 2037, owing to increasing awareness about colorectal cancer and need to develop innovative cancer treatment solutions in the region.
The major players in the market are Genentech, Inc., Eli Lilly and Company, F. Hoffman-La Roche AG, and Bristol Myers Squibb, among others.
